Some clinicians have explored maintaining patients on 1.0 mg weekly after goal weight achievement, particularly for those experiencing persistent side effects
Our patient Daniel (33 years old, 280 lbs, 10 years with psoriasis and PsA) saw dramatic improvements with GLP-1 therapyweight loss, reduced pain and swelling, healthier skin, and a reduced need for medications after 6 months
If your BMI is at least 27, you can qualify if you also have at least one weight-related condition, such as high cholesterol, type 2 diabetes, or high blood pressure
A clear sign of tolerance development
Safe injection technique is essential to ensure the medication is delivered correctly, minimise discomfort, and reduce the risk of complications such as infection or poor drug absorption
5-8 In this regard, it is well recognised that the secretion and action of GIP and GLP-1 is disturbed in obesity and T2D, 5-10,16-18 which could also directly impact skeletal health